Frontedge Study
CRF version 1.0 of 12/06/2025
Protocol Frontedge
Identi
F
y att
R
ibutes
O
f u
N
controlled severe as
T
hma patients tr
E
ate
D
with
tezepelumab: the Italian clinical practice study with the new
biolo
G
ic targ
E
ting TSLP
Copyright © 2025 FULLCRO S.R.L. - TUTTI I DIRITTI RISERVATI
per contatti riguardanti lo Studio Frontedge
Frontedge@fullcro.org